Raymond James Financial Services Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-116,267
| Closed | -$2.16M | – | 3439 |
|
|
2023
Q3 | $2.16M | Sell |
116,267
-78,085
| -40% | -$1.45M | ﹤0.01% | 1463 |
|
|
2023
Q2 | $2.15M | Buy |
194,352
+27,976
| +17% | +$309K | ﹤0.01% | 1468 |
|
|
2023
Q1 | $2.23M | Sell |
166,376
-3,501
| -2% | -$47K | ﹤0.01% | 1422 |
|
|
2022
Q4 | $2.1M | Sell |
169,877
-6,802
| -4% | -$84.1K | ﹤0.01% | 1413 |
|
|
2022
Q3 | $2.47M | Buy |
176,679
+23,611
| +15% | +$329K | 0.01% | 1315 |
|
|
2022
Q2 | $2.11M | Buy |
153,068
+2,355
| +2% | +$32.5K | ﹤0.01% | 1406 |
|
|
2022
Q1 | $2.45M | Sell |
150,713
-12,072
| -7% | -$196K | ﹤0.01% | 1376 |
|
|
2021
Q4 | $2.65M | Buy |
162,785
+11,474
| +8% | +$187K | ﹤0.01% | 1358 |
|
|
2021
Q3 | $2.25M | Buy |
151,311
+71,097
| +89% | +$1.06M | ﹤0.01% | 1426 |
|
|
2021
Q2 | $1.6M | Buy |
80,214
+8,398
| +12% | +$168K | ﹤0.01% | 1633 |
|
|
2021
Q1 | $1.66M | Buy |
71,816
+26,893
| +60% | +$621K | ﹤0.01% | 1510 |
|
|
2020
Q4 | $1.11M | Sell |
44,923
-8,074
| -15% | -$200K | ﹤0.01% | 1638 |
|
|
2020
Q3 | $2.2M | Sell |
52,997
-18,448
| -26% | -$765K | 0.01% | 1122 |
|
|
2020
Q2 | $3.42M | Buy |
71,445
+17,030
| +31% | +$816K | 0.01% | 870 |
|
|
2020
Q1 | $3.43M | Buy |
54,415
+51,101
| +1,542% | +$3.22M | 0.01% | 654 |
|
|
2019
Q4 | $411K | Sell |
3,314
-3,243
| -49% | -$402K | ﹤0.01% | 2100 |
|
|
2019
Q3 | $435K | Buy |
6,557
+3,575
| +120% | +$237K | ﹤0.01% | 1994 |
|
|
2019
Q2 | $237K | Sell |
2,982
-301
| -9% | -$23.9K | ﹤0.01% | 2423 |
|
|
2019
Q1 | $367K | Buy |
+3,283
| New | +$367K | ﹤0.01% | 2100 |
|
|
2018
Q4 | – | Sell |
-5,517
| Closed | -$697K | – | 2841 |
|
|
2018
Q3 | $697K | Buy |
+5,517
| New | +$697K | ﹤0.01% | 1683 |
|